|

Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease

RECRUITINGN/ASponsored by University Hospital, Montpellier
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Montpellier
Started2024-05-31
Est. completion2028-06
Eligibility
Age1 Year – 5 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06431269

Summary

Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease

Eligibility

Age: 1 Year – 5 YearsHealthy volunteers accepted
Inclusion Criteria:

* Congenital heart disease with stable status defined by last operation \>3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
* Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
* Patient aged 1 to 5 years.
* No previous medical diagnosis of NDD
* Parental or legal guardian's consent.
* Social security affiliation (for France only)

Exclusion Criteria:

* Patients with a genetic or poly-malformative syndrome with known neurological impairment.
* Neurodevelopmental disorder already known/treated
* Neurodevelopmental status evaluation within the last 6 months.

Conditions3

Congenital Heart Disease in ChildrenHeart DiseaseNeurodevelopmental Disorders

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.